RJA
ATRC icon

Raymond James & Associates’s AtriCure ATRC Stock Holding History

Raymond James & Associates’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,145
Closed -$240K – 3924
2022
Q3 		$240K Sell
6,145
-11,272
-65% -$516K ﹤0.01% 3316
2022
Q2 		$712K Sell
17,417
-4,768
-21% -$226K ﹤0.01% 2677
2022
Q1 		$1.46M Sell
22,185
-389
-2% -$25.2K ﹤0.01% 2352
2021
Q4 		$1.57M Sell
22,574
-2,197
-9% -$160K ﹤0.01% 2331
2021
Q3 		$1.72M Buy
24,771
+1,401
+6% +$108K ﹤0.01% 2207
2021
Q2 		$1.85M Buy
23,370
+5,602
+32% +$407K ﹤0.01% 2153
2021
Q1 		$1.16M Buy
17,768
+2,298
+15% +$142K ﹤0.01% 2404
2020
Q4 		$861K Buy
15,470
+6,734
+77% +$291K ﹤0.01% 2439
2020
Q3 		$349K Buy
+8,736
New +$370K ﹤0.01% 2860
2017
Q3 		– Sell
-30,000
Closed -$728K – 3407
2017
Q2 		$728K Hold
30,000
– – ﹤0.01% 2213
2017
Q1 		$575K Hold
30,000
– – ﹤0.01% 2292
2016
Q4 		$587K Hold
30,000
– – ﹤0.01% 2239
2016
Q3 		$475K Hold
30,000
– – ﹤0.01% 2322
2016
Q2 		$424K Hold
30,000
– – ﹤0.01% 2192
2016
Q1 		$505K Hold
30,000
– – ﹤0.01% 2034
2015
Q4 		$673K Sell
30,000
-9,193
-23% -$189K ﹤0.01% 1835
2015
Q3 		$859K Buy
39,193
+9,193
+31% +$230K ﹤0.01% 1671
2015
Q2 		$739K Hold
30,000
– – ﹤0.01% 1871
2015
Q1 		$615K Hold
30,000
– – ﹤0.01% 1938
2014
Q4 		$599K Hold
30,000
– – ﹤0.01% 1865
2014
Q3 		$442K Hold
30,000
– – ﹤0.01% 1898
2014
Q2 		$551K Hold
30,000
– – ﹤0.01% 1794
2014
Q1 		$564K Sell
30,000
-10,000
-25% -$205K ﹤0.01% 1733
2013
Q4 		$747K Hold
40,000
– – 0.01% 1476
2013
Q3 		$439K Hold
40,000
– – ﹤0.01% 1645
2013
Q2 		$380K Buy
+40,000
New +$348K ﹤0.01% 1629

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Raymond James & Associates's ATRC Position: Q4 2022 in Review

Raymond James & Associates sold out of AtriCure (ATRC) in Q4 2022, closing a stake of 6,145 shares — an estimated $240K sold.

Raymond James & Associates first reported a position in ATRC in Q2 2013 and held it in 26 quarters. The position peaked at $1.85M in Q2 2021. 211 funds tracked by Wall St. Rank hold ATRC as of Q4 2022.

  • Raymond James & Associates reported no remaining AtriCure position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 6,145 AtriCure shares in Q4 2022, an estimated $240K.
  • Raymond James & Associates first reported a position in AtriCure in Q2 2013 and held it in 26 quarters.
  • Raymond James & Associates's AtriCure position peaked at $1.85M in Q2 2021.
  • 211 funds tracked by Wall St. Rank held AtriCure as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.